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There is evidence that pluripotent stem cells found in fetal liver and adult bone marrow of 
the mouse can repopulate the myeloid and lymphoid tissues of irradiated  mice (1-4). This 
evidence has been accumulated in part by examining the histological and functional charac- 
teristics of spleen colonies obtained by the method of Till and McCulloch (5). Each spleen 
colony in this assay is the progeny of a single colony-forming  unit (cfu) or stem cell. Thus, a 
pluripotent cell in the bone marrow has the potential to differentiate along a variety of path- 
ways depending upon the inductive stimulus which it receives. The problem of the mechanism 
and control of differentiation of the hemopoietic stem cell to the various fully differentiated 
stages is of great importance in several areas of research. 
In  this  communication we  report  the  production  of  an  antibody  to  the 
colony-forming unit. The source of antigen was mouse brain. It is known that 
mouse brain has  an antigen cross-reactive with  the 0  antigen on thymocytes 
and  thymus-derived cells  (T  cells)  (6).  We  have  previously shown  (7)  that 
immunization of rabbits or goats with mouse brain resulted in antisera which 
had the properties of anti-0 antisera. These antisera were cytotoxic for mouse 
thymocytes but not for bone marrow cells, did not reduce the number of plaque- 
forming cells in an immune response  (thus demonstrating that  they did not 
have anti-B cell activity), and prevented a  graft-versus-host  reaction and the 
induction of  a  primary immune response in vitro. We have now tested these 
antisera for the ability to prevent the formation of hemopoietic colonies (anti- 
cfu activity) and have found an apparent anti-stem cell antibody. 
Materials and Methods 
Animals.--CBA, C57BL/6, and BDF1 [(C57BL/6  >( DBA/2)F1] mice were bred in our 
colony using stocks obtained from Jackson Laboratory,  Bar Harbor,  Maine. BALB/cJ mice 
were obtained from Jackson Laboratory. Animals were maintained  five to a cage with drinking 
water containing 11 ppm chlorine at pH 2.8 (8). 
Anti-Brain Antisera.--The method previously described (7, 9) was used. Mouse brain was 
homogenized in a Sorval Omnimixer (Ivan Sorvall, Inc., Norwalk, Conn.) and emulsified in 
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Freund's complete adjuvant (Difco Laboratories, Inc., Detroit, Mich.). Rabbits or goats were 
injected with 3 ml of the mixture and bled at suitable intervals after secondary injections. 
Colony-Forming Unit Assay.--The method of Till and  McCulloch was used  (5).  Groups 
of mice were X-irradiated using a G.E. Maxitron machine (General Electric Co., Pleasanton, 
Calif.). The conditions of irradiation were 250 kv, 15 ma, 2.5 mm copper, and 1 mm aluminum 
filtration, head height 51 cm, 50 R/rain. The total dose was 800 R  delivered in a split dose of 
400 R  on each of 2 days. Suitable numbers of normal syngeneic bone marrow cells were ob- 
tained from femurs and  tibias, washed,  and injected intravenously. After 10 days the mice 
were sacrificed,  the spleens  placed in Bouin's solution, and the number of colonies  counted. 
Bone marrow cells treated with antiserum were treated as follows: 1 X  107 bone marrow cells 
in 0.1 ml buffer  (7) were reacted with 0.1 ml of a 1/3 dilution of the antiserum. The antiserum 
was absorbed before use with erythrocytes of the strain of mouse being used.  After 30 rain in 
the  cold,  guinea pig complement  (1/5)  (Hyland  Div., Travenol Laboratories,  Inc.,  Costa 
Mesa, Calif.) was added and incubated at 37°C for 1 hr. 
Cytotoxiclty and Absorptions.--Performed as described previously (7, 9). 
TABLE  I 
Effect of Goat Anti-CBA Brain Antiserum on the Establishment o/Spleen  Colonies 
Treatment  of  Bone marrow  cells*  Fetal  liver 
cells* 
bone marrow  CBA  C57BL/6  BDFa  CBA 
Goat  anti  CBA brain  0.7  -4-  0.6,  +  1.1  -4-  0.9  0.9  ±  0.3  0.4  zh  0.1 
Gnat  anti-BDF1  brain§  --[I  --  1.2  4-  0.3 
Normal  goat  serum  I6  4-  2.3  11  4-  1.4  13  4-  1.2  15  --  1.2 
Rabbit  anti-BALB/c  brain  0.8  i  0.2  --  --  -- 
Normal  rabbit  serum  17  ±  1.9  --  -- 
* 6  X  104 C57BL/6 and BDF1  bone marrow  cells or 1 X  105 CBA bone marrow  cells;  l0  s CBA  fetal  liver cells 
injected  into  lethally irradiated  syngeneic  mice. 
:~ Colonies  at  day  10 4-  standard  error. 
§ From  Dr.  R. W.  Dutton. 
[] Not  done. 
RESULTS 
Effect of A nti-Brain Antisera on Colony-Forming  Units.--Three preparations 
of anti-mouse  brain  antisera were tested  for their ability to inhibit colony for- 
marion.  Goat  anti-CBA  brain,  goat  anti-BDF1  brain  (kindly provided by Dr. 
R.  W.  Dutton),  and  rabbit  anti-BALB/c  brain  were tested.  Normal  goat and 
normal  rabbit  sera were used  as controls.  Bone marrow  from CBA,  C57BL/6, 
and  BDFa  mice were  tested,  as was  fetal liver from CBA.  After treatment  of 
the cells as described  in Materials  and  Methods,  appropriate  numbers  of cells 
were  injected  into  lethally  irradiated  syngeneic  recipients.  6  X  104  C57BL/6 
and  BDF1,  1  >(  10 '~  CBA  bone  marrow,  or  1  )<  106  CBA  fetal  liver cells 
from day 19 embryos were injected intravenously and the number of cfu deter- 
mined  10  days  later.  The  results  of  typical  experiments  are  seen  in  Table  I. 
The  anti-brain  antisera  inhibited  colony formation  in  all cases. 
Effecl  of Absorption  of Anliserum  on  Colony-Forming  Unit  Inhibition  and 
A nti-Thymocyte Cytotoxicity.--These  antisera  showed  no  cytotoxicity for bone 
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had high titers of anti-thymocyte activity. It was important to determine if 
the two activities of the sera could be separated by absorption. Accordingly, 
samples of the anti-brain antisera were absorbed with brain, thymus, or liver 
and  the  absorbed  antisera  tested for both  inhibition  of colony-forming unit 
activity and anti-thymocyte cytotoxic activity. The results of these experiments 
TABLE  II 
Effect of Absorption of Goat Anti-CBA  Brain Antiserum 
on the Inhibition of Spleen Colonies 
Goat anti-CBA brain*  Colonies/10  ~ CBA  Anti-thymus 
absorbed with  bone marrows  %  killing (corrected 
for background)§ 
CBA brain  12.0  4-  1.8  9 
BDF1 brain  11.4 -4-  1.6  9 
CBA thymus  1.I  4-  0.5  7 
CBA liver  3.8  4-  1.2  100 
Rat brain  4.2  4-  i. I  7 
Human brain  2.6  4-  1.3  5 
Normal goat serum  (control)  13.1  4-  1.5  -- 
* 1 g brain tissue was shredded and washed and used to absorb 1 ml of mouse RBC-absorbed goat anti-mouse 
brain antiserum. Final dilution of the serum was 1/12. 
1 X  10  a treated CBA bone marrow cells injected into 800 R CBA recipients. Colonies at day 10 9= standard 
error. 
%  experimental dead  -  %  control dead 
§ %  killing (corrected for background):  X  100. 
100 -  %  control dead 
TABLE  III 
Elect of Various Anti-Brain Antisera on the Ability 
of Mouse Bone Marrow to Form Colonies 
Colonies/105  CBA bone marrow* 
Goat anti-CBA brain  1 4-  0.3 
Rabbit anti-BALB/c brain  0.8  4-  0.2 
Rabbit antl-rat brain  11  4-  1.7 
Rabbit anti-human brain  20 4-  1.3 
Rabbit anti-dog brain  12  4-  1.3 
Normal goat serum  18  4-  2.0 
Normal rabbit serum  17  4-  1.9 
I0  treated CBA bone marrow cells injected into 800 R  CBA recipients. Colonies at day 10 4- standard  *IX  ,5 
error. 
are seen in Table II. It is clear from the data in the table that absorption with 
brain or thymus removed all of the anti-thymus cytotoxic activity of the anti- 
sera. Absorption with liver did not reduce the potency of the antisera against 
thymus cells or cfu. The anti-stem cell activity of the antiserum was removed 
only after absorption with brain and not after absorption with thymus. Thus 
the two activities of the anti-brain antisera could be separated by absorption 
with thymocytes. 
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activity of the antisera  (data not shown)  but this is probably due to the fact 
that the cell with the relevant antigen, the stem cell,  is in such low concentra- 
tion in the bone marrow (see Table I). It is of interest that only mouse brain 
absorbed anti-cfu activity. This is in contrast to our other findings (9)  that the 
brains of most species contain  an  antigen  which  cross-reacts with  the mouse 
brain-associated thymus antigen (BA0). We tested the possibility that we were 
missing the absorption of the anti-stem cell  antibody by brain tissue of other 
species by testing higher dilutions of antiserum absorbed with rat brain. Even 
at the ends of the titration curve we found no inhibition of cfu. 
Effect  of  Anti-Brain  Antisera  to  Other  Species  on  Mouse  Colony-Forming 
Units.--To  further test the question  of sharing of cross-reactive brain-associ- 
ated stem cell antigen between the mouse and other species, antisera against 
rat, dog, and human brain were tested on mouse bone marrow cells. The results 
of these experiments are seen in Table III. Only the anti-mouse brain antisera 
had  activity against  the mouse stem cell. 
DISCUSSION 
The data in the present study show that there is an antigen on brain which 
is  shared  by the hemopoietic colony-forming unit  or stem cell.  Neither  liver 
nor thymus shares this antigen.  The brain also has an antigen which it shares 
with thymocytes (0)  (6)  and antisera against brain  are active against  thymo- 
cytes (7). Absorption of the anti-brain antisera with thymocytes removes anti- 
thymus activity (7, 9) but does not remove anti-stem cell activity. 
The brain also shares an antigen with liver and lymphoma cells (R. Hyman 
and E. S. Golub, unpublished data). Anti-brain antisera are cytotoxic for both 
0  + and 0- lymphomas. Absorption of the antisera with thymus only does not 
remove  the  cytotoxic  effect  for  either.  Absorption  with  liver  only  removes 
cytotoxicity for 0- lymphomas but not for 0  + lymphomas. This probably indi- 
cates an antibody with another specificity in the antiserum. We are currently 
testing the effect of these  antisera on other tumors and also the effect of the 
antisera on the lymphomas after absorption with other tumors. Antisera against 
mouse brain  also contains  an antibody against mouse erythrocytes. The anti- 
body raised against CBA or BALB/c brain, for example, reacts with the eryth- 
rocytes of eight different  strains  and  seems to be independent  of any known 
histocompatibility antigen. 1 
It is  also known  that  brain  contains  the  PC1  antigen  which  is shared  by 
plasma cells  (10).  The anti-stem cell  antibody is different from anti-PC1  anti- 
body which  could be obtained from PC1  positive strains  (CBA is PC1  nega- 
tive) because the anti-brain sera used in this study have no anti-plaque-forming 
1 Golub, E. S. Brain associated erythrocyte antigen (BAeryth) : an antigen shared by brain 
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cell activity. Nor do the sera have anti-precursor activity since  treated bone 
marrow cells are able to cooperate with untreated thymus ceils in an irradiated 
host  (Cudkowicz and Miller, personal communication). 
The anti-mouse brain  antiserum has been shown to inhibit cfu in vitro  (J. 
Watson  and  E.  S.  Golub,  unpublished  data)  and  there  is  a  possibility  that 
anti-human brain antiserum has anti-human cfu activity. We are testing this 
possibility in vitro. The experiments here also show that each of the strains of 
mice tested has the antigen on a subpopulation of cells in its bone marrow. If 
there are alleles of this stem cell antigen as there are with 0 (4) the heterologous 
species (goat or rabbit) may not be able to detect a difference. This is the case 
with brain-associated 0 (6). Van Bekkum and his coworkers have been able to 
concentrate the colony-forming cell by gradient centrifugation (11). Hopefully 
a  combination of these enrichment techniques  and  the anti-cfu antibody will 
provide a powerful tool for the study of the stem cell. 
One can only speculate upon the significance of the fact that the brain of the 
mouse has at least four and possibly five identified antigens common to lymph- 
oid  tissue.  At  least  two  of  these  antigens,  0  and  PC1,  are  "developmental 
antigens"  (12). As other antigens are characterized it will be of interest to de- 
termine  if  the  brain,  with  its  blood-brain  barrier  sequestered  antigens,  is  a 
reservoir of the potential antigens which stem cells can express at various stages 
of differentiation along the myeloid and lymphoid lines. The fact that an anti- 
body apparently against the cfu is now available, in any case, provides a potent 
tool for elucidating the differentiative pathways of the stem cell. 
SUMMARY 
There is an antigen on mouse brain tissue which is shared by the hemopoietic 
colony-forming unit or stem cell of the mouse. Treatment of bone marrow or 
fetal liver cells with  anti-brain  antisera inhibits  expression of colony-forming 
units.  The anti-stem cell  antibody is not  absorbed by  thymus cells and  thus 
can be distinguished  from the  anti-thymocyte  antibody which  these  antisera 
also contain. 
I  thank Mrs. Elaine McDaniel for her highly competent assistance. Dr. J. Ferebee, Basset 
Hospital, Cooperstown, N. Y., provided the human brain used as antigen, the rabbit anti-dog 
brain antiserum, and, most important, the initial urging to test our anti-brain antisera for 
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